|
Name |
3-Methyl-6-hydroxy-8-methoxy-3,4-dihydroisocoumarin
|
Molecular Formula | C11H12O4 | |
IUPAC Name* |
6-hydroxy-8-methoxy-3-methyl-3,4-dihydroisochromen-1-one
|
|
SMILES |
CC1CC2=C(C(=CC(=C2)O)OC)C(=O)O1
|
|
InChI |
InChI=1S/C11H12O4/c1-6-3-7-4-8(12)5-9(14-2)10(7)11(13)15-6/h4-6,12H,3H2,1-2H3
|
|
InChIKey |
WGUHOBJSLARYHD-UHFFFAOYSA-N
|
|
Synonyms |
3-Methyl-6-hydroxy-8-methoxy-3,4-dihydroisocoumarin; MEGxm0_000188; ACon1_001199; NCGC00169582-01; NCGC00169582-02; BRD-A35656996-001-01-9; 6-hydroxy-8-methoxy-3-methyl-3,4-dihydroisochromen-1-one; 944711-09-5; Pyrenocin A - NCGC00169582-02_C11H12O4_1H-2-Benzopyran-1-one, 3,4-dihydro-6-hydroxy-8-methoxy-3-methyl-
|
|
CAS | NA | |
PubChem CID | 16757192 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 208.21 | ALogp: | 1.9 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 55.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.717 |
Caco-2 Permeability: | -4.588 | MDCK Permeability: | 0.00001750 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.195 |
Blood-Brain-Barrier Penetration (BBB): | 0.813 | Plasma Protein Binding (PPB): | 75.84% |
Volume Distribution (VD): | 0.771 | Fu: | 16.65% |
CYP1A2-inhibitor: | 0.932 | CYP1A2-substrate: | 0.751 |
CYP2C19-inhibitor: | 0.221 | CYP2C19-substrate: | 0.483 |
CYP2C9-inhibitor: | 0.081 | CYP2C9-substrate: | 0.911 |
CYP2D6-inhibitor: | 0.706 | CYP2D6-substrate: | 0.819 |
CYP3A4-inhibitor: | 0.235 | CYP3A4-substrate: | 0.187 |
Clearance (CL): | 13.563 | Half-life (T1/2): | 0.79 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.144 |
Drug-inuced Liver Injury (DILI): | 0.623 | AMES Toxicity: | 0.039 |
Rat Oral Acute Toxicity: | 0.039 | Maximum Recommended Daily Dose: | 0.378 |
Skin Sensitization: | 0.289 | Carcinogencity: | 0.077 |
Eye Corrosion: | 0.035 | Eye Irritation: | 0.876 |
Respiratory Toxicity: | 0.268 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005248 | 0.681 | D07MGA | 0.360 | ||||
ENC000960 | 0.681 | D0C1SF | 0.293 | ||||
ENC005249 | 0.681 | D03SKD | 0.277 | ||||
ENC000757 | 0.673 | D0L1JW | 0.274 | ||||
ENC005001 | 0.619 | D0J4IX | 0.272 | ||||
ENC005578 | 0.600 | D0X5KF | 0.268 | ||||
ENC004821 | 0.600 | D0E9CD | 0.268 | ||||
ENC005942 | 0.600 | D09PJX | 0.265 | ||||
ENC001451 | 0.600 | D04TDQ | 0.248 | ||||
ENC005004 | 0.587 | D0S5CH | 0.246 |